PH PATEWOOD HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $7M
- Transactions
- 876
- Companies
- 40
- Average per transaction
- $7,938
Who reported the payments
| Gilead | $3,404,080 |
| Indivior Inc. | $461,504 |
| Edwards Lifesciences | $422,298 |
| AstraZeneca | $349,293 |
| Regeneron | $339,700 |
| Medtronic | $336,795 |
| Intercept Pharmaceuticals, Inc. | $170,163 |
| Incyte Corporation | $161,814 |
| Astrazeneca UK Limited | $146,866 |
| Aadi Bioscience, Inc. | $130,398 |
| Merck | $120,700 |
| CSL Behring | $115,395 |
| Laminate Medical Technologies Inc. | $104,526 |
| Intercept Pharma Europe Ltd. | $74,644 |
| Ardelyx, Inc. | $68,987 |
| Novartis | $65,347 |
| ADC Therapeutics America, Inc. | $37,320 |
| Microvention, Inc. | $37,050 |
| Neurocrine Biosciences, Inc. | $36,626 |
| Johnson & Johnson | $35,735 |
| AbbVie | $29,307 |
| Genentech, Inc. | $26,967 |
| Merit Medical Systems Inc | $26,468 |
| OPKO Pharmaceuticals, LLC | $26,250 |
| Shire North American Group Inc | $23,454 |
| Global Blood Therapeutics, Inc. | $21,410 |
| Silk Road Medical, Inc. | $20,953 |
| Morphosys AG | $14,750 |
| Acadia Pharmaceuticals Inc | $14,645 |
| Acerta Pharma LLC | $12,369 |
| Veryan Medical Incorporated | $12,200 |
| Imperative Care, Inc | $11,000 |
| Sanofi US Services Inc. | $10,554 |
| SPR Therapeutics, Inc | $10,315 |
| Inari Medical, Inc. | $9,949 |
| Endologix LLC | $9,435 |
| Anika Therapeutics, Inc. | $8,694 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | $7,088 |
| Stryker | $6,894 |
| Zimmer Biomet | $6,144 |